Core Insights - Aier Eye Hospital in Wuxi has successfully hosted the "Global ICL Surgery Volume Ten Consecutive Championships Expert Meeting," showcasing its expertise in ICL (Implantable Collamer Lens) surgeries and attracting numerous eye care experts and patients [1][10] - Since 2015, Aier Eye Hospital has completed over 550,000 ICL surgeries, maintaining its position as the global leader in this field for ten consecutive years, reflecting both technological advantages and patient trust in the Aier brand [1][8] Group 1: Technology and Expertise - ICL surgery is highlighted for its unique advantages, including non-invasive nature, preservation of the eye's original structure, and reversibility, making it a safer option for patients with high myopia and other complex eye conditions [2][4] - The hospital has established a team of experienced experts who provide personalized surgical plans based on comprehensive pre-operative assessments, ensuring high-quality visual outcomes for patients [4][10] Group 2: Patient Experience and Community Engagement - Patient testimonials during the event emphasized the trust in the hospital's technology and team, with employees sharing their positive experiences as both medical professionals and patients [5][7] - The event also served as a platform for promoting eye health knowledge and community service, with Aier Eye Hospital committed to making advanced myopia correction techniques accessible to more citizens [10] Group 3: Recognition and Future Plans - Aier Eye Hospital received the "Global ICL Surgery Volume First Medical Institution (2015-2025)" certification from STAAR Surgical, acknowledging its leadership and contributions in the ICL field [8][10] - The hospital plans to continue advancing ICL technology alongside other surgical methods, aiming to provide more personalized and safer visual health services for diverse patient populations [10]

Core Viewpoint - He Eye Hospital has officially launched the "EVO ICL Intraocular Lens Specialty Outpatient Clinic," marking an upgrade in the refined management of refractive services [1] Group 1: Company Developments - He Eye Hospital will collaborate with STAAR Surgical to establish "EVO ICL Project Demonstration Centers" in Shenyang and Dalian, and a "EVO ICL Clinical Cooperation Center" in Anshan, creating a precise diagnosis and treatment network in Liaoning [1] - The company aims to standardize the training system for refractive talent and accelerate the promotion of innovative technologies and treatment concepts, providing personalized visual quality solutions with unified technical standards and regulated treatment processes [1] Group 2: Market Insights - China, as the country with the largest population of myopia, has a significant demand for refractive surgery, with the refractive surgery market expected to grow from 5.9 billion yuan in 2015 to 72.5 billion yuan by 2025, representing a compound annual growth rate of 28.51% [1] - The continuous breakthroughs in refractive surgery technology are crucial for improving the quality of life for adults with myopia, enhancing convenience in sports and work, and expanding career development opportunities for young people [1] Group 3: Technological Advancements - ICL implantation surgery is highlighted as a major breakthrough in myopia correction, offering unique advantages such as reversibility, a wide correction range, enhanced night vision, and UV protection, providing safer and more precise solutions for patients [2] - He Eye Hospital has been engaged in refractive services for nearly 30 years, leveraging its expert team and focusing on technological innovation, academic leadership, and service models to continuously upgrade surgical techniques [2] - The AI-driven personalized femtosecond surgery utilizes AI technology to accurately obtain corneal aberration data, creating visualized personalized models and showcasing different aberration optimization schemes, thus meeting diverse patient needs and initiating a new transformation in AI-driven surgical procedures [2]